Research programme: chronic obstructive pulmonary disease therapeutics - LTT Bio-Pharma

Drug Profile

Research programme: chronic obstructive pulmonary disease therapeutics - LTT Bio-Pharma

Alternative Names: LT-0302; mepenzolate bromide - LTT Bio-Pharma

Latest Information Update: 15 Oct 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator LTT Bio-Pharma
  • Class Anti-inflammatories; Bronchodilators; Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Research Chronic obstructive pulmonary disease

Most Recent Events

  • 14 Aug 2015 LTT Bio-Pharma has international patent protection for COPD therapeutics
  • 13 Aug 2015 Early research in Chronic obstructive pulmonary disease in Japan before august 2015 (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top